Vijaya Diagnostic Centre shareholding pattern

VIJAYA

1317

76.10 (6.13%)
Last updated on 2 Jun, 2026 | 15:49 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Vijaya Diagnostic Centre Shareholding Pattern

  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

52.51%

Mutual Fund

29.06%

Insurance

0.51%

Foreign Institutional Investors

13.38%

Domestic Institutional Investors

0.36%

Retail

4.18%

Others

0%

Total Promoters
MAR '26
52.51%

Summary

Vijaya Diagnostic Centre share holding pattern reports the following shareholding: Vijaya Diagnostic Centre Total Promoters is at 52.51%, Mutual Fund at 29.06%, Insurance at 0.51%, Foreign Institutional Investors at 13.38%, Domestic Institutional Investors at 0.36%, and Retail at 4.18%. This breakdown provides a quick snapshot of ownership distribution for Vijaya Diagnostic Centre share holding pattern in 2026-27.

Vijaya Diagnostic Centre FAQs

As of 06-2026, the promoter shareholding in Vijaya Diagnostic Centre stands at 52.51% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Vijaya Diagnostic Centre is 13.38% and 0.36% respectively.

The retail shareholding of the Vijaya Diagnostic Centre is 4.18%.

Changes in shareholding patterns of Vijaya Diagnostic Centre can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Vijaya Diagnostic Centre are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost